DUBLIN--(BUSINESS WIRE)--The "Global Cholesterol Testing Devices Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The Global Cholesterol Testing Devices Market to grow at a CAGR of 6.98% during the period 2018-2022.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend affecting this market is the launch of innovative products. Vendors in the market are offering products with improved features and manufacturing standards to create their mark in the market.
According to the report, one driver influencing this market is the high incidence of CVDs. The increasing incidences of cardiovascular diseases increases the adoption of cholesterol testing devices for monitoring the level of cholesterol.
Further, the report states that one challenge affecting this market is the product recalls. Product recalls affect the company's revenue as well as the long-term prospects by hampering consumer confidence and the company's brand image.
Market Trends
- Launch of Innovative Products
- Increased Online Presence of Vendors
- Increased M&A
Key Vendors
- Abaxis
- Abbott
- ACON Laboratories
- Akers Biosciences
- F. Hoffmann-La Roche
Key Topics Covered
1. Executive Summary
2. Scope of the Report
3. Research Methodology
4. Market Landscape
5. Market Sizing
6. Five Forces Analysis
7. Customer Landscape
8. Market Segmentation by End-User
9. Regional Landscape
10. Decision Framework
11. Drivers and Challenges
12. Market Trends
13. Vendor Landscape
14. Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/9mrjrm/cholesterol?w=4
